PROZ / Switzerland / Research
Swiss research
Research groups across Switzerland working on psychedelic pharmacology, therapy, neuroscience, and public health.
Directory
Active groups
Entries reproduce the current PROZ compendium. Most were last checked in October or November 2025; follow the official links for current details.
Center for Addiction Disorders
ZürichAddictive disorders, neuroimaging, neurophysiology, and epidemiology.
PD Dr. Marcus Herdener↗Clinical Research Group for Substance-Assisted Therapy
BaselLong-term effects, LSD, and psychedelic-assisted therapy.
PD Dr. Felix Müller↗Liechti Lab
BaselPsychopharmacology and pharmacokinetics, in vitro and in vivo.
Prof. Dr. Matthias Liechti↗Molecular Psychiatry
FribourgNeuroscience, adverse effects, phenomenology, and psychedelic therapy.
Prof. Dr. Gregor Hasler↗Pharmaco-Neuroimaging and Cognitive-Emotional Processing
ZürichEmotional and cognitive processes, neurobiology, and pharmacology.
PD Dr. Katrin Preller↗Psychedelic Research & Therapy Development
ZürichPsychedelic therapy development and neuropsychopharmacology.
Dr. Milan Scheidegger↗PSYCHE Project
LausanneCommunity-based participatory research, psychedelic-assisted psychotherapy, and knowledge translation.
Dr. Xavier Mabire↗Soravia Group
BernPsychoneuroendocrinology, neuronal mechanisms, and psychedelic-assisted psychotherapy.
Prof. Dr. Leila Soravia & Prof. Dr. Tobias Bracht↗University Hospital Geneva
GenevaPsychedelic-assisted therapy and psychotherapy research.
Prof. Dr. Daniele Zullino and colleagues↗Clinical information
Therapy resources
PROZ is an educational student association, not a treatment provider.